I wonder what, "The resources are a bit thin now due to the latest last minute double cross, taking the deal down from $11.25 million to $7.5 million. Just awful people. Shame, shame on us. " means?!?!?!?!?
barcode,looks like a very difficult environment till they get topline results and they are just doing the best they can. They must of got less financing than they were promised and had no choice to go forward with the deal cause they needed the money. They are short staffed but they could save themselves more money by having a good finance guy than working Les 22 hours a day. He is nice guy but not a great negotiator. imho brownies and andrew dice clay?
barcode, I do think LP & LG have done a great job getting us this close to the end of Phase III DC-Vax trial and we will all be rewarded with it's success. Sorry for focusing on difficult financings for a small biotech. I believe in Dr.Liau and the tremendous science of her research for two decades. We should focus on the results of topline data.